Samuel Valable
4
Documents
Identifiants chercheurs
- samuel-valable
- ResearcherId : B-7578-2008
- 0000-0003-0355-0270
- IdRef : 085766127
- ResearcherId : http://www.researcherid.com/rid/B-7578-2008
Présentation
samuel valable,hypoxia
Publications
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 4
- 1
- 1
|
Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical StudyCancers, 2020, 12 (12), pp.3585. ⟨10.3390/cancers12123585⟩
Article dans une revue
hal-03082539v1
|
|
Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent GenesCancers, 2020, 12 (8), pp.2019. ⟨10.3390/cancers12082019⟩
Article dans une revue
hal-02912590v1
|
|
VCAM-1 Targeted Alpha-Particle Therapy for Early Brain MetastasesNeuro-Oncology, 2019, 22 (3), pp.357-368. ⟨10.1093/neuonc/noz169⟩
Article dans une revue
hal-02346582v1
|
M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastomaOncotarget, 2017, 8 (42), pp.72597-72612. ⟨10.18632/oncotarget.19994⟩
Article dans une revue
hal-02100869v1
|